Experienced in Venous Thromboembolism (VTE)

Dr. William Wood

Radiology
Office
860 Omni Blvd Ste 303, 
Newport News, VA 
Clinical Trials:Currently Recruiting for 1 Trial
20 Years of Experience
Experienced in Venous Thromboembolism (VTE)
Office
860 Omni Blvd Ste 303, 
Newport News, VA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Wood is a Radiologist in Newport News, Virginia. Dr. Wood has been practicing medicine for over 20 years and is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Acute Lymphoblastic Leukemia (ALL), Mantle Cell Lymphoma (MCL), and Venous Thromboembolism (VTE).

His clinical research consists of co-authoring 267 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Venous Thromboembolism (VTE).

Specialties
Radiology
Licenses
Diagnostic Radiology in VA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

Office
860 Omni Blvd Ste 303, Newport News, VA 23606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Phase II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Peripheral T Cell Lymphoma
Phase II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Peripheral T Cell Lymphoma
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Biological, Drug
Study Drugs: ATLCAR.CD30 T cells, Bendamustine, Fludarabine, Cyclophosphamide
Study Phase: Phase 2
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure
Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma
Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological
Study Drug: ATLCAR.CD30 cells
Study Phase: Phase 1/Phase 2
Phase I Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Prevention of Relapse of CD30+ Lymphomas After High Dose Therapy and Autologous Stem Transplantation (ATLAS)
Phase I Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Prevention of Relapse of CD30+ Lymphomas After High Dose Therapy and Autologous Stem Transplantation (ATLAS)
Enrollment Status: Active_not_recruiting
Publish Date: May 15, 2025
Intervention Type: Drug
Study Drug: Anti-CD30 CAR-T Cells
Study Phase: Phase 1
INSPIRE: A Multicenter Randomized Controlled Trial Integrating Health Informatics in a Scalable Stepped Care Self-Management Program for Survivors After Hematopoietic Cell Transplantation
INSPIRE: A Multicenter Randomized Controlled Trial Integrating Health Informatics in a Scalable Stepped Care Self-Management Program for Survivors After Hematopoietic Cell Transplantation
Enrollment Status: Completed
Publish Date: January 29, 2025
Intervention Type: Other
Study Phase: Phase 3
The STEPP Study: Sensors To Evaluate Physical Performance
The STEPP Study: Sensors To Evaluate Physical Performance
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Other
Study Phase: Not Applicable
Feasibility Study of a Home-Based Exercise Intervention Program for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Feasibility Study of a Home-Based Exercise Intervention Program for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Enrollment Status: Completed
Publish Date: April 20, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
The Impact of a Physical Activity Intervention in Older Patients Undergoing Adjuvant Chemotherapy for Colorectal Cancer: a Randomized, Controlled Trial
The Impact of a Physical Activity Intervention in Older Patients Undergoing Adjuvant Chemotherapy for Colorectal Cancer: a Randomized, Controlled Trial
Enrollment Status: Completed
Publish Date: May 01, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
LCCC 1410: Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older
LCCC 1410: Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older
Enrollment Status: Completed
Publish Date: April 30, 2020
Intervention Type: Behavioral
Study Phase: Not Applicable
Ixazomib for Treatment of Chronic Graft vs. Host Disease
Ixazomib for Treatment of Chronic Graft vs. Host Disease
Enrollment Status: Completed
Publish Date: February 06, 2019
Intervention Type: Other, Drug
Study Phase: Phase 2
Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer
Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer
Enrollment Status: Completed
Publish Date: June 06, 2018
Intervention Type: Behavioral
LCCC 1409: The CARE Program: CAncer REhabilitation Pilot Study for Older Adults
LCCC 1409: The CARE Program: CAncer REhabilitation Pilot Study for Older Adults
Enrollment Status: Completed
Publish Date: September 12, 2017
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Wait-list Controlled Clinical Trial: the Effect of a Physical Activity Program on Fatigue After Potentially Curative Chemotherapy Among Cancer Survivors Age 65 or Older -- PACT (Physical Activity After Chemotherapy)
A Randomized, Wait-list Controlled Clinical Trial: the Effect of a Physical Activity Program on Fatigue After Potentially Curative Chemotherapy Among Cancer Survivors Age 65 or Older -- PACT (Physical Activity After Chemotherapy)
Enrollment Status: Completed
Publish Date: September 12, 2017
Intervention Type: Behavioral
Study Phase: Not Applicable
View 12 Less Clinical Trials

267 Total Publications

Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.
Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.
Journal: JCO oncology practice
Published: October 02, 2025
Similar Doctors
Experienced in Venous Thromboembolism (VTE)
Dr. William Marshall
Radiology
Experienced in Venous Thromboembolism (VTE)
Dr. William Marshall
Radiology

Riverside Regional Medical Center

500 J Clyde Morris Blvd, 
Newport News, VA 
 (1.9 miles away)
757-594-2911
Languages Spoken:
English
See accepted insurances

William Marshall is a Radiologist in Newport News, Virginia. Dr. Marshall is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Swyer-James Syndrome, Breast Lump, Gallbladder Disease, and CAPOS Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wood's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile